NCT05648591View on ClinicalTrials.gov

Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 24, 2023

Primary Completion Date

March 31, 2026

Study Completion Date

November 30, 2026

Conditions
SchizophreniaBipolar I Disorder
Interventions
DRUG

Iloperidone

oral tablet

Trial Locations (9)

30030

RECRUITING

Vanda Investigational Site, Decatur

30318

RECRUITING

Vanda Investigational Site, Atlanta

30331

RECRUITING

Vanda Investigational Site, Atlanta

44125

RECRUITING

Vanda Investigational Site, Garfield Heights

44145

NOT_YET_RECRUITING

Vanda Investigational Site, Westlake

45221

RECRUITING

Vanda Investigational Site, Cincinnati

72204

RECRUITING

Vanda Investigational Site, Little Rock

80202

RECRUITING

Vanda Investigational Site, Denver

98201

RECRUITING

Vanda Investigational Site, Everett

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY